Ignite Creation Date:
2025-12-25 @ 12:33 AM
Ignite Modification Date:
2025-12-28 @ 7:52 AM
Study NCT ID:
NCT00403767
Status:
COMPLETED
Last Update Posted:
2014-04-29
First Post:
2006-11-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation
Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-12
Start Date Type:
None
Primary Completion Date:
2010-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-09
Completion Date Type:
ACTUAL
First Submit Date:
2006-11-23
First Submit QC Date:
None
Study First Post Date:
2006-11-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-12-02
Results First Submit QC Date:
None
Results First Post Date:
2012-07-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2011-04-29
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2014-04-10
Last Update Post Date:
2014-04-29
Last Update Post Date Type:
ESTIMATED